Optimizing the dosing interval of buprenorphine in a multimodal postoperative analgesic strategy in the rat: Minimizing side-effects without affecting weight gain and food intake

Laboratory Animals

Volumn 46, Issue 4, 2012, Pages 287-292

  Schaap, Manon W H ^a,b   Uilenreef, Joost J ^a,b   Mitsogiannis, Manuela D ^b,c   Van't Klooster, José G ^c   Arndt, Saskia S ^b,c   Hellebrekers, Ludo J ^a,b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Body weight; Buprenorphine; Dosing interval; Pica; Rat

Indexed keywords

BUPRECARE; BUPRENORPHINE; MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; ELECTROMYOGRAPHY; FOOD INTAKE; GROWTH RATE; MALE; NONHUMAN; PETRI DISH; PICA; POSTOPERATIVE ANALGESIA; RAT; WEIGHT GAIN;

ANALGESICS, OPIOID; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BUPRENORPHINE; DRUG THERAPY, COMBINATION; ELECTRODES, IMPLANTED; FEEDING BEHAVIOR; INJECTIONS, SUBCUTANEOUS; MALE; NEUROSURGICAL PROCEDURES; PAIN, POSTOPERATIVE; PICA; POSTOPERATIVE CARE; RATS; RATS, WISTAR; THIAZINES; THIAZOLES; TIME FACTORS; WEIGHT GAIN;

ANIMALIA; RATTUS;

EID: 84872472420     PISSN: 00236772     EISSN: None     Source Type: Journal    
DOI: 10.1258/la.2012.012058     Document Type: Article

References (23)

1. Christoph T, Kögel B, Schiene K, Méen M, De Vry J, Friderichs E. Broad analgesic profile of buprenorphine in rodent models of acute and chronic pain. Eur J Pharmacol 2005;507:87-98
2. Roughan JV, Flecknell PA. Buprenorphine: a reappraisal of its antinociceptive effects and therapeutic use in alleviating postoperative pain in animals. Lab Anim 2002;36:322-43
3. Stokes EL, Flecknell PA, Richardson CA. Reported analgesic and anaesthetic administration to rodents undergoing experimental surgical procedures. Lab Anim 2009;43:149-54
4. Curtin LI, Grakowsky JA, Suarez M, et al. Evaluation of buprenorphine in a postoperative pain model in rats. Comp Med 2009;59:60-71
5. Cooper DM, Hoffman W, Wheat N, Lee H. Duration of effects on clinical parameters and referred hyperalgesia in rats after abdominal surgery and multiple doses of analgesic. Comp Med 2005;55:344-53
6. Ohtani M, Kotaki H, Sawada Y, Iga T. Comparative analysis of buprenorphine-and norbuprenorphine-induced analgesic effects based on pharmacokinetic-pharmacodynamic modeling. J Pharmacol Exp Ther 1995;272:505-10
7. Ohtani M, Kotaki H, Uchino K, Sawada Y, Iga T. Pharmacokinetic analysis of enterohepatic circulation of buprenorphine and its active metabolite, norbuprenorphine, in rats. Drug Metab Dispos 1994;22:2-7
8. Cowan A, Lewis JW, Macfarlane IR. Agonist and antagonist properties of buprenorphine, a new antinociceptive agent. Br J Pharmacol 1977;60:537-45
9. McKeon GP, Pacharinsak C, Long CT, et al. Analgesic effects of tramadol, tramadol-gabapentin, and buprenorphine in an incisional model of pain in rats (Rattus norvegicus). J Am Assoc Lab Anim Sci 2011;50:192-7
10. Liles JH, Flecknell PA. The effects of buprenorphine, nalbuphine and butorphanol alone or following halothane anaesthesia on food and water consumption and locomotor movement in rats. Lab Anim 1992;26:180-9
11. Thompson AC, Kristal MB, Sallaj A, Acheson A, Martin LB, Martin T. Analgesic efficacy of orally administered buprenorphine in rats: methodologic considerations. Comp Med 2004;54:293-300
12. Clark JA, Myers PH, Goelz MF, Thigpen JE, Forsythe DB. Pica behavior associated with buprenorphine administration in the rat. Lab Anim Sci 1997;3:300-3
13. Jacobson C. Adverse effects on growth rates in rats caused by buprenorphine administration. Lab Anim 2000;34:202-6
14. Hellyer PW, Robertson SA, Fails AD. Pain and its management. In: Tranquilli WJ, Thurmon JC, Grimm KA, eds. Lumb and Jones' Veterinary Anesthesia and Analgesia. 4th edn. Ames: Blackwell Publishing, 2007:31-57
15. Kehlet H, Dahl JB. The value of 'multimodal' or 'balanced analgesia' in postoperative pain treatment. Anesth Analg 1993;77:1048-56
16. Hrapkiewicz K, Medina L. Rats. In: Hrapkiewicz K, Medina L, eds. Clinical Laboratory Animal Medicine: An Introduction. 3rd edn. Ames: Blackwell Publishing, 2007:79-111
17. Field AP. Discovering Statistics Using SPSS: and Sex and Drugs and Rock 'n' Roll. 3rd edn. London: Sage Publications, 2009
18. Anil S, Anil L, Deen J. Challenges of pain assessment in domestic animals. J Am Vet Med Assoc 2002;220:313-19
19. Sotocinal SG, Sorge RE, Zaloum A, et al. The rat grimace scale: a partially automated method for quantifying pain in the laboratory rat via facial expressions. Mol Pain 2011;7:55
20. Bomzon A. Are repeated doses of buprenorphine detrimental to postoperative recovery after laparotomy in rats? Comp Med 2006;56:114-18
21. Roughan JV, Flecknell PA. Behaviour-based assessment of the duration of laparotomy-induced abdominal pain and the analgesic effects of carprofen and buprenorphine in rats. Behav Pharmacol 2004;15:461-72
22. Brennan MP, Sinusas AJ, Horvath TL, Collins JG, Harding MJ. Correlation between body weight changes and postoperative pain in rats treated with meloxicam or buprenorphine. Lab Anim (NY) 2008;38:87-93
23. Villegas I, Alarcón de la Lastra C, Martín MJ, Motilva V, La Casa García C. Gastric damage induced by subchronic administration of preferential cyclooxygenase-1 and cyclooxygenase-2 inhibitors in rats. Pharmacology 2002;66:68-75